These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4889468)

  • 1. Clinical studies with a new rifamycin derivative.
    Cohn HD
    J Clin Pharmacol J New Drugs; 1969; 9(2):118-25. PubMed ID: 4889468
    [No Abstract]   [Full Text] [Related]  

  • 2. The Australian rifampicin trial.
    Proust AJ
    Med J Aust; 1971 Jul; 2(2):85-94. PubMed ID: 4999365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rifamide and rifamycin SV: some comparative observations on kinetics in man].
    Acocella G; Pallanza R; Santilli E; Nicolis FB
    Antibiotica; 1966 Mar; 4(1):17-48. PubMed ID: 5960847
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of an intravenous infusion of rifamycin SV on the excretion of bilirubin, bromsulphalein, and indocyanine green in man.
    Acocella G; Nicolis FB; Tenconi LT
    Gastroenterology; 1965 Nov; 49(5):521-5. PubMed ID: 5322057
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of rifamycin SV on pigment excretion in rats.
    Acocella G; Billing BH
    Gastroenterology; 1965 Nov; 49(5):526-30. PubMed ID: 5851728
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacology and toxicology of rifamide.
    Dezulian V; Serralunga MG; Maffii G
    Toxicol Appl Pharmacol; 1966 Jan; 8(1):126-37. PubMed ID: 5950859
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifamycin SV. A review.
    Bergamini N; Fowst G
    Arzneimittelforschung; 1965 Aug; 15(8):Suppl:951-1002. PubMed ID: 5320355
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatic storage and excretion of bilirubin in man.
    Raymond GD; Galambos JT
    Am J Gastroenterol; 1971 Feb; 55(2):135-44. PubMed ID: 5580257
    [No Abstract]   [Full Text] [Related]  

  • 9. [Kinetic rate constant changes of Rifampicin and bilirubin serum levels following single and repeated administration of different per kg doses in humans].
    Curci G; Bergamini N; Delli Veneri F; Ninni A; Nitti V
    Arch Monaldi; 1970; 25(6):427-40. PubMed ID: 5514802
    [No Abstract]   [Full Text] [Related]  

  • 10. [Several supplementary investigations on rifampicin (rifamycin AMP)].
    Kitamoto O; Fukaya K; Tomori G; Suzuki T
    Jpn J Antibiot; 1970 Jun; 23(3):273-5. PubMed ID: 5312212
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of phenobarbital on hyperbilirubinemia induced in heterozygote Gunn and Wistar rats].
    Christoforov B; Deraedt R; Foliot A; Petite JP
    Pathol Biol (Paris); 1970; 18(11):663-7. PubMed ID: 4915805
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rifampicin and its clinical use].
    Fafrowicz B
    Wiad Lek; 1971 Jul; 24(3):233-8. PubMed ID: 4926926
    [No Abstract]   [Full Text] [Related]  

  • 13. Alteration in biliary bilirubin content and nonerythropoietically derived bilirubin synthesis in rats after alpha-naphthylisothiocyanate administration.
    Roberts RJ; Plaa GL
    J Pharmacol Exp Ther; 1968 Jun; 161(2):382-8. PubMed ID: 5650144
    [No Abstract]   [Full Text] [Related]  

  • 14. [Constitutional hyperbilirubinemia and mixed bilirubin. Clinical and functional study].
    Rapaccini GL; Anti M; Miggiano G; De Vitis I; De Simone F; Fedeli G
    Minerva Med; 1980 Nov; 71(44):3221-8. PubMed ID: 7454089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary report on the clinical trial of a new antibiotic--Rifocin (rifamycin sv).
    Amaku EO
    West Afr Med J Niger Pract; 1968 Dec; 17(6):281-2 passim. PubMed ID: 4883474
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease.
    Smith DL; Shire NJ; Watts NB; Schmitter T; Szabo G; Zucker SD
    J Clin Densitom; 2006; 9(1):105-13. PubMed ID: 16731439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The patient presenting with isolated hyperbilirubinemia.
    Fabris L; Cadamuro M; Okolicsanyi L
    Dig Liver Dis; 2009 Jun; 41(6):375-81. PubMed ID: 19196555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on rifampicin. I. Penetration into the bone in man after single dose of 750 mg.
    Vacek V; Hejzlar M; Pavlansky R
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):217-9. PubMed ID: 4917426
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fasting hyperbilirubinemia].
    Tazawa Y
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):277-8. PubMed ID: 9645060
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quantitative aspects of osmotic opening of the blood-brain barrier in experimental hyperbilirubinemia].
    Domínguez Ortega F; Martín Zarza M; Ormazábal Ramos JC; Rodríguez Luis JC; Doménech Martínez E
    An Esp Pediatr; 1993 Dec; 39(6):493-7. PubMed ID: 8166402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.